Endocrinology
Prediabetes
Identify prediabetes with fasting glucose, HbA1c, or oral glucose tolerance testing; then stratify progression risk by glycemic burden and prioritize structured weight-loss and activity intervention, adding metformin selectively for patients at highest risk of type 2 diabetes.
Testing
Whom to screen and which test to order
Use screening to identify patients who can be referred to a proven prevention intervention.
Screen asymptomatic adults aged 35 to 70 years with overweight or obesity for prediabetes and type 2 diabetes. Acceptable screening tests are HbA1c, fasting plasma glucose (FPG), and the 75-g oral glucose tolerance test (OGTT). The result should trigger a documented prevention plan rather than diagnosis alone. JAMA+2JAMANew USPSTF Recommendations for Screening for Prediabetes and Type 2 Diabetes: An Opportunity to CreateCDC[PDF] preventing chronic disease - CDCCDCPrevalence of Testing for Diabetes Among US Adults With Overweight or Obesity, 2016–2019
Order FPG when a fasting specimen is feasible and HbA1c when fasting access is a barrier. Use a 75-g OGTT when post-load dysglycemia is clinically important to resolve, including postpartum testing after gestational diabetes; the test requires overnight fasting followed by a standardized 75-g glucose load and plasma glucose measurement at fasting and 2 hours. jacc+1jacc2026 AHA/ACC/ADA/ASN Guideline for the Prevention ... - JACCNatureGlucose Tolerance Testing and Diabetes Risk Assessment | Endocrinology | Clinical Sciences | Health sciences | Topics | Nature Index
A single abnormal screening result establishes a prevention opportunity but does not identify a uniform-risk population. Most patients meet only one glycemic definition; documenting whether abnormalities are present on one, two, or all three tests improves risk discussion and prioritization of intensive intervention. WileyWileyReframing prediabetes: A call for better risk stratification and intervention - Kim - 2024 - Journal of Internal Medicine - Wiley Online Library
HbA1c 5.7% to 6.4% identifies prediabetes; HbA1c values of 6.0% to 6.4% have been recognized as particularly high risk for future diabetes. JAMA+2JAMANew USPSTF Recommendations for Screening for Prediabetes and Type 2 Diabetes: An Opportunity to CreateScienceDirectAssociations of HbA1c and fasting plasma glucose with incident diabetes: Implications for pre-diabetes thresholds in a Japanese population - ScienceDirectWileyMetformin: Therapeutic profile in the treatment of type 2 diabetes
FPG 100 to 125 mg/dL identifies impaired fasting glucose by ADA criteria. JAMA+2JAMANew USPSTF Recommendations for Screening for Prediabetes and Type 2 Diabetes: An Opportunity to CreateOxford AcademicPrediabetes and the risk of atrial fibrillation: systematic review, meta ...publications aapManagement of Newly Diagnosed Type 2 Diabetes Mellitus (T2DM ...
Two-hour plasma glucose 140 to 199 mg/dL after a 75-g OGTT identifies impaired glucose tolerance. ScienceDirect+1ScienceDirectAssociations of HbA1c and fasting plasma glucose with incident diabetes: Implications for pre-diabetes thresholds in a Japanese population - ScienceDirectWileyMetformin: Therapeutic profile in the treatment of type 2 diabetes
Use plasma glucose-based testing when a diagnostic OGTT is required after gestational diabetes; a 4- to 12-week postpartum OGTT is recommended. jaccjacc2026 AHA/ACC/ADA/ASN Guideline for the Prevention ... - JACC
Risk
Stratify by glycemic burden and reproductive history
Intensity should follow diabetes risk, not the diagnostic label alone.
Classify glycemic burden by the number of abnormal prediabetes criteria. Patients with one abnormal criterion represent an elevated-risk group, whereas two abnormal criteria identify higher risk and all three identify very high risk for progression; this framework is useful when deciding how urgently to deploy intensive lifestyle treatment, pharmacotherapy, and follow-up. WileyWileyReframing prediabetes: A call for better risk stratification and intervention - Kim - 2024 - Journal of Internal Medicine - Wiley Online Library
Impaired fasting glucose and impaired glucose tolerance are not interchangeable phenotypes. FPG detects fasting dysglycemia, while OGTT identifies post-load dysglycemia; a patient with normal FPG may still have impaired glucose tolerance, and a patient with either phenotype warrants a prevention intervention. Nature+2NatureGlucose Tolerance Testing and Diabetes Risk Assessment | Endocrinology | Clinical Sciences | Health sciences | Topics | Nature IndexScienceDirectAssociations of HbA1c and fasting plasma glucose with incident diabetes: Implications for pre-diabetes thresholds in a Japanese population - ScienceDirectWileyMetformin: Therapeutic profile in the treatment of type 2 diabetes
A history of gestational diabetes materially changes preventive priority. In women with both prior gestational diabetes and prediabetes, a post hoc Diabetes Prevention Program analysis found that 12 months of lifestyle intervention or metformin improved glycemic control and reduced type 2 diabetes risk by 50% to 60% versus controls. jaccjacc2026 AHA/ACC/ADA/ASN Guideline for the Prevention ... - JACC
Prioritize high-intensity referral for patients with multiple abnormal glycemic tests rather than assuming risk is identical across HbA1c-, FPG-, and OGTT-defined prediabetes. WileyWileyReframing prediabetes: A call for better risk stratification and intervention - Kim - 2024 - Journal of Internal Medicine - Wiley Online Library
For women with gestational diabetes, schedule the postpartum OGTT before delivery or at discharge and complete testing at 4 to 12 weeks postpartum. jaccjacc2026 AHA/ACC/ADA/ASN Guideline for the Prevention ... - JACC
Address food, housing, and medication insecurity when building a prevention plan for younger adults, who have low testing and prevention-program participation rates and may face disproportionate social barriers. JAMAJAMANew USPSTF Recommendations for Screening for Prediabetes and Type 2 Diabetes: An Opportunity to Create
First-line prevention
Prescribe a structured lifestyle intervention rather than general advice
The strongest preventive effect comes from a behavioral program with explicit weight and activity targets.
Refer patients with prediabetes to a structured combined diet, physical-activity, and behavioral program rather than offering unstructured counseling alone. The Diabetes Prevention Program intensive lifestyle intervention targeted approximately 7% loss of initial body weight through a low-calorie, low-fat dietary pattern plus at least 150 minutes weekly of moderate-intensity physical activity and reduced incident diabetes by 58%. jacc+1jaccPrimary Prevention of Cardiovascular Disease in Diabetes MellitusDiabetes JournalsThe National Clinical Care Commission Report to Congress: Leveraging Federal Policies and Programs to Prevent Diabetes in People With Prediabetes | Diabetes Care | American Diabetes Association
Make the prescription measurable: set an initial weight-loss target of approximately 7% of baseline weight, schedule at least 150 minutes per week of moderate-intensity activity, and use goal planning and self-monitoring of dietary intake, activity, and weight. Long-term follow-up data support sustained benefit from intensive lifestyle intervention. jacc+2jacc2026 AHA/ACC/ADA/ASN Guideline for the Prevention ... - JACCjaccPrimary Prevention of Cardiovascular Disease in Diabetes MellitusDiabetes JournalsThe National Clinical Care Commission Report to Congress: Leveraging Federal Policies and Programs to Prevent Diabetes in People With Prediabetes | Diabetes Care | American Diabetes Association
When access is limited, prioritize referral to an established diabetes prevention lifestyle-change program. National policy recommendations specifically emphasize improving clinician referral, payment coverage, and availability of National Diabetes Prevention Program and Medicare Diabetes Prevention Program services because screening without connection to intervention leaves preventable risk unaddressed. Diabetes JournalsDiabetes JournalsThe National Clinical Care Commission Report to Congress: Leveraging Federal Policies and Programs to Prevent Diabetes in People With Prediabetes | Diabetes Care | American Diabetes Association
Frame the intervention as diabetes prevention, not solely weight management: lifestyle programs reduce progression to diabetes in high-risk adults. acpjournals+1acpjournalsLifestyle Interventions for Patients With and at Risk for Type 2 Diabetes: A Systematic Review and Meta-analysis: Annals of Internal Medicine: Vol 159, No 8ScienceDirectLong-term lifestyle intervention can reduce the development of type 2 diabetes mellitus in subjects with prediabetes: A systematic review and meta-analysis - ScienceDirect
Use combined diet and physical-activity programs; the Community Preventive Services Task Force recommends this model for adults at increased type 2 diabetes risk. ScienceDirect+1ScienceDirectValue of Lifestyle Intervention to Prevent Diabetes and Sequelae - ScienceDirectPubMedValue of lifestyle intervention to prevent diabetes and sequelae - PubMed
For postpartum patients with gestational diabetes, include metabolic risk-factor optimization alongside lifestyle treatment. jaccjacc2026 AHA/ACC/ADA/ASN Guideline for the Prevention ... - JACC
Adjunctive therapy
When to add metformin for diabetes prevention
Use metformin selectively as an adjunct to—not a substitute for—structured lifestyle intervention.
Consider metformin for patients with prediabetes who remain at high risk after 3 to 6 months of intensive lifestyle management, particularly patients who are younger, have overweight or obesity, have worsening glycemia, or have high cardiovascular risk. This is a selective prevention strategy rather than routine drug treatment for every patient with one mildly abnormal glycemic result. WileyWileyMetformin: Therapeutic profile in the treatment of type 2 diabetes
Clinical trial and synthesis data describe preventive efficacy with metformin doses usually totaling at least 1,500 mg/day. In the Diabetes Prevention Program, metformin reduced diabetes incidence by 31% versus placebo over a mean 2.8 years, compared with a larger effect from intensive lifestyle intervention; the reduction persisted at 10 years, with an 18% lower diabetes incidence reported in follow-up. jacc+1jaccPrimary Prevention of Cardiovascular Disease in Diabetes MellitusPubMedThe Effectiveness of Metformin in Diabetes Prevention: A Systematic Review and Meta-Analysis - PMC
Use metformin as off-label prevention therapy in the United States; federal recommendations have called for FDA review and approval for diabetes prevention, underscoring that this is not an FDA-approved prevention indication. Check estimated glomerular filtration rate before prescribing and monitor renal function; published review data support use down to eGFR 30 mL/min/1.73 m² with appropriate caution and dose/renal monitoring. Wiley+1WileyMetformin: Therapeutic profile in the treatment of type 2 diabetesDiabetes JournalsThe National Clinical Care Commission Report to Congress: Leveraging Federal Policies and Programs to Prevent Diabetes in People With Prediabetes | Diabetes Care | American Diabetes Association
Favor lifestyle intervention over metformin when the patient can engage in the full program, because the Diabetes Prevention Program lifestyle arm produced a greater reduction in incident diabetes than metformin. jacc+2jaccPrimary Prevention of Cardiovascular Disease in Diabetes MellitusDiabetes JournalsThe National Clinical Care Commission Report to Congress: Leveraging Federal Policies and Programs to Prevent Diabetes in People With Prediabetes | Diabetes Care | American Diabetes AssociationPubMedThe Effectiveness of Metformin in Diabetes Prevention: A Systematic Review and Meta-Analysis - PMC
Discuss metformin early for prior gestational diabetes with prediabetes, where both metformin and lifestyle intervention reduced diabetes risk by 50% to 60% versus controls in a post hoc analysis. jaccjacc2026 AHA/ACC/ADA/ASN Guideline for the Prevention ... - JACC
Do not present metformin as a replacement for activity, dietary change, or weight-loss goals; available prevention studies evaluated it alongside lifestyle-focused management. Wiley+1WileyMetformin: Therapeutic profile in the treatment of type 2 diabetesPubMedThe Effectiveness of Metformin in Diabetes Prevention: A Systematic Review and Meta-Analysis - PMC
Longitudinal care
Monitor glycemia, program engagement, and progression risk
Follow-up should determine whether prevention is working and whether the patient has crossed into diabetes.
At follow-up, repeat the glycemic modality that identified the abnormality when possible, reassess weight and weekly activity against the approximately 7% and 150-minute targets, and determine whether the patient enrolled in and is attending a structured program. Failure to enroll is a treatment failure of access or implementation, not simply a patient preference issue. jacc+2jacc2026 AHA/ACC/ADA/ASN Guideline for the Prevention ... - JACCjaccPrimary Prevention of Cardiovascular Disease in Diabetes MellitusDiabetes JournalsThe National Clinical Care Commission Report to Congress: Leveraging Federal Policies and Programs to Prevent Diabetes in People With Prediabetes | Diabetes Care | American Diabetes Association
Escalate prevention intensity when glycemia worsens, when a second or third prediabetes criterion becomes abnormal, or when lifestyle targets are not being met despite structured support. Multiple abnormal glycemic criteria identify progressively higher diabetes risk and provide a practical trigger to revisit metformin, social barriers, and program delivery. Wiley+1WileyReframing prediabetes: A call for better risk stratification and intervention - Kim - 2024 - Journal of Internal Medicine - Wiley Online LibraryWileyMetformin: Therapeutic profile in the treatment of type 2 diabetes
Postpartum follow-up requires particular rigor: complete the 4- to 12-week OGTT after gestational diabetes, identify prediabetes or diabetes promptly, and continue metabolic risk-factor optimization because prior gestational diabetes confers a high-risk prevention phenotype. jaccjacc2026 AHA/ACC/ADA/ASN Guideline for the Prevention ... - JACC
Track weight change from baseline rather than relying on self-reported dietary adherence alone; the evidence-based program target is approximately 7% initial weight loss. jacc+1jaccPrimary Prevention of Cardiovascular Disease in Diabetes MellitusDiabetes JournalsThe National Clinical Care Commission Report to Congress: Leveraging Federal Policies and Programs to Prevent Diabetes in People With Prediabetes | Diabetes Care | American Diabetes Association
Track documented weekly moderate-intensity activity against the at-least-150-minutes-per-week target. jacc+1jacc2026 AHA/ACC/ADA/ASN Guideline for the Prevention ... - JACCjaccPrimary Prevention of Cardiovascular Disease in Diabetes Mellitus
Reassess pharmacologic prevention if high-risk patients have worsening glycemia despite 3 to 6 months of intensive lifestyle management. WileyWileyMetformin: Therapeutic profile in the treatment of type 2 diabetes
References
- New USPSTF Recommendations for Screening for Prediabetes and Type 2 Diabetes: An Opportunity to Create — jamanetwork.com · jamanetwork.com
- 2026 AHA/ACC/ADA/ASN Guideline for the Prevention ... - JACC — www.jacc.org · www.jacc.org
- Optimal exercise dose for glycemic control in prediabetes across ... — www.cell.com · www.cell.com
- Primary Prevention of Cardiovascular Disease in Diabetes Mellitus — www.jacc.org · www.jacc.org
- Glucose Tolerance Testing and Diabetes Risk Assessment | Endocrinology | Clinical Sciences | Health sciences | Topics | Nature Index — www.nature.com · www.nature.com
- Lifestyle Interventions for Patients With and at Risk for Type 2 Diabetes: A Systematic Review and Meta-analysis: Annals of Internal Medicine: Vol 159, No 8 — www.acpjournals.org · www.acpjournals.org
- “Preventing the Progression: The Power of Lifestyle Interventions in Prediabetic Individuals—A Systematic Review” - Bhardwaj - Clinical Endocrinology - Wiley Online Library — onlinelibrary.wiley.com · onlinelibrary.wiley.com
- Prediabetes and the risk of atrial fibrillation: systematic review, meta ... — academic.oup.com · academic.oup.com
- Lower-Intensity Interventions for Prediabetes: A Systematic Review - ScienceDirect — www.sciencedirect.com · www.sciencedirect.com
- Long-term lifestyle intervention can reduce the development of type 2 diabetes mellitus in subjects with prediabetes: A systematic review and meta-analysis - ScienceDirect — www.sciencedirect.com · www.sciencedirect.com
- Predisease: When Does it Make Sense? - Oxford Academic — academic.oup.com · academic.oup.com
- Value of Lifestyle Intervention to Prevent Diabetes and Sequelae - ScienceDirect — www.sciencedirect.com · www.sciencedirect.com
- A call to action on prediabetes : JAAPA — journals.lww.com · journals.lww.com
- Reframing prediabetes: A call for better risk stratification and intervention - Kim - 2024 - Journal of Internal Medicine - Wiley Online Library — onlinelibrary.wiley.com · onlinelibrary.wiley.com
- Associations of HbA1c and fasting plasma glucose with incident diabetes: Implications for pre-diabetes thresholds in a Japanese population - ScienceDirect — www.sciencedirect.com · www.sciencedirect.com
- Metformin: Therapeutic profile in the treatment of type 2 diabetes — dom-pubs.onlinelibrary.wiley.com · dom-pubs.onlinelibrary.wiley.com
- The National Clinical Care Commission Report to Congress: Leveraging Federal Policies and Programs to Prevent Diabetes in People With Prediabetes | Diabetes Care | American Diabetes Association — diabetesjournals.org · diabetesjournals.org
- The Effectiveness of Metformin in Diabetes Prevention: A Systematic Review and Meta-Analysis - PMC — www.ncbi.nlm.nih.gov · www.ncbi.nlm.nih.gov
- Metformin for people with impaired glucose tolerance or impaired fasting blood glucose - Lü, Q - 2010 | Cochrane Library — www.cochranelibrary.com · www.cochranelibrary.com
- Value of lifestyle intervention to prevent diabetes and sequelae - PubMed — www.ncbi.nlm.nih.gov · www.ncbi.nlm.nih.gov
- [PDF] preventing chronic disease - CDC — www.cdc.gov · www.cdc.gov
- Management of Newly Diagnosed Type 2 Diabetes Mellitus (T2DM ... — publications.aap.org · publications.aap.org
- Prevalence of Testing for Diabetes Among US Adults With Overweight or Obesity, 2016–2019 — www.cdc.gov · www.cdc.gov
- Time to Glucose Peak During an Oral Glucose Tolerance Test Identifies Prediabetes Risk - PMC — www.ncbi.nlm.nih.gov · www.ncbi.nlm.nih.gov